Detection of human papillomavirus DNA by the hybrid capture assay

Carvalho, Maria Odete O; Almeida, Ricardo W; Leite, Fátima M. S; Fellows, Ilza B; Teixeira, Mariza H; Oliveira, Ledy H. S; Cavalcanti, Silvia M. B.
Braz. j. infect. dis ; 7(2): 121-125, Apr. 2003. tab
Artículo en Inglés | LILACS | ID: lil-351155

Documentos relacionados

  1. Association of Diet Quality and Dietary Components with Clinical Resolution of HPV.
  2. Persistent HPV infection after conization of cervical intraepithelial neoplasia-- a systematic review and meta-analysis.
  3. Local Hyperthermia at 44°C Is Effective in Clearing Cervical High-Risk Human Papillomaviruses: A Proof-of-Concept, Randomized Controlled Clinical Trial.
  4. Outcome and associated factors of high-risk human papillomavirus infection without cervical lesions.
  5. Prevalence and significance of HPV DNA detection below the clinical threshold of the commercial kit Alinity m HR-HPV assay (Abbott).
  6. Acceleration of cervical cancer diagnosis with human papillomavirus testing below age 30: Observational study.
  7. Evaluation of co-testing with cytology and human papillomavirus testing in cervical screening.
  8. HPV-induced host epigenetic reprogramming is lost upon progression to high-grade cervical intraepithelial neoplasia.
  9. Women 50 Years and Older With Negative Pap Test and Positive Human Papillomavirus Test for Genotypes Other Than 16 and 18-Follow-up Outcomes.
  10. The clinical relevance of human papillomavirus negative status in unsatisfactory cervical cytology.